In a report released today, Brian Tanquilut from Jefferies reiterated a Buy rating on Acadia Healthcare (ACHC), with a price target of $42. The company’s shares opened today at $31.44.
According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of 4.9% and a 52.8% success rate. Tanquilut covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, Quest Diagnostics Inc, and Surgery Partners Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Acadia Healthcare with a $40.45 average price target, representing a 28.7% upside. In a report issued on November 14, Citigroup also maintained a Buy rating on the stock with a $43 price target.
.
See today’s analyst top recommended stocks >>
Acadia Healthcare’s market cap is currently $2.77B and has a P/E ratio of 12.28. The company has a Price to Book ratio of 1.03.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. It operates through the following segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities, and Corporate and Other.
